ePrints

The Quadruplet Combination of Carfilzomib, Cyclophosphamide, Lenalidomide, and Dexamethasone is Safe and Well Tolerated as Induction Therapy for Newly Diagnosed, Transplant Eligible, Myeloma Patients

Lookup NU author(s): Professor Graham Jackson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Pawlyn C, Davies F, Cairns D, Collett C, Jones J, Kaiser M, Chalmers A, Striha A, Milligan D, Lindsay J, Chapman C, Allotey D, Shafeek S, Karunanithi K, Cook G, Russell N, Drayson M, Owen R, Gregory W, Jackson G, Morgan G

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 20th Congress of the European Hematology Association

Year of Conference: 2015

Pages: 152

Print publication date: 01/06/2015

Acceptance date: 01/04/2015

ISSN: 0390-6078

Publisher: Fondazione Ferrata Storti

URL: http://www.haematologica.org/content/100/supplement_1/1.full.pdf+html

Series Title: Haematologica

Share